West-Ward Pharmaceuticals Corp. has voluntarily recalled 18,053 units of Dexamethasone Sodium Phosphate Injection, USP (4 mg/mL), in both 1 mL and 5 mL vials. This prescription corticosteroid is being recalled because testing identified high levels of an impurity or degradation product known as Dexamethasone adduct, which exceeded the approved safety specifications. The affected medication was distributed nationwide in the United States and Puerto Rico in shelf packs containing 25 vials each.
The presence of impurities or degradation products above specified limits can potentially alter the safety or effectiveness of the medication. While the risk is categorized as low, using a drug that does not meet quality standards may not provide the intended therapeutic benefit or could cause unexpected side effects.
Contact healthcare provider and return to pharmacy.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.